Ken-Ichi Ito
12PUBLICATIONS
36CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Mar 05, 2026
EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells.Teruo Nakamura, Tomohiro Shibata, Ken-Ichi Ito
|Jun 25, 2025
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies.Aya Imai, Ryo Tsunashima, Yu Hidaka
|Jan 21, 2023
The Advantage of Using an Optical See-Through Head-Mounted Display in Ultrasonography-Guided Needle Biopsy Procedures: A Prospective Randomized Study.Tadafumi Shimizu, Takaaki Oba, Ken-Ichi Ito
|Jun 20, 2022
Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells.Koichi Ohno, Tomohiro Shibata, Ken-Ichi Ito
|Apr 17, 2022
Surgical resection of the primary tumor prevents an undesirable locoregional condition and improves the quality of life in patients with anaplastic thyroid cancer.Toshiharu Kanai, Tokiko Ito, Hiroki Morikawa
Pageof 2
Frequent Collaborators
1 joint publications
Yuki Sugiyama
1 joint publications
Kunihiro Mitsuzawa
1 joint publications
Yuki Yoshiyama
1 joint publications
Hiroyuki Agatsuma
1 joint publications
Tadafumi Shimizu
1 joint publications
Ryo Tsunashima
1 joint publications
Yu Hidaka
1 joint publications
Sae Kitano
1 joint publications
Chikage Kato
1 joint publications
Akira Watanabe